Daxor Corporation Implements Blood Volume Analysis Program at High-Volume Ohio Cardiology Center

Daxor Corporation has announced the implementation of its Blood Volume Analysis (BVA) program at a high-volume cardiology center in Ohio. The move marks an expansion of Daxor’s customer base and highlights the growing adoption of its diagnostic technology in clinical settings. The program aims to enhance patient care by providing precise blood volume measurements, which are critical for managing conditions such as heart failure and other cardiovascular diseases.

The Ohio-based cardiology center, known for handling a significant number of patients annually, will integrate Daxor’s BVA-100 diagnostic system into its clinical workflow. This system is designed to deliver accurate and actionable data to assist physicians in tailoring treatment plans based on individual patient needs. According to Daxor, the addition of this program aligns with their broader strategy to expand access to advanced diagnostic tools across key healthcare markets.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 8, 2026

Author

GOAI